{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:15:15Z","timestamp":1788434115968,"version":"build-2803163510"},"reference-count":32,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Sleep disturbances are highly prevalent in patients with chronic migraine (CM) and are increasingly recognized as major contributors to disease burden and headache chronification. Growing evidence suggests that dysregulation of calcitonin gene-related peptide (CGRP) signaling and central sensitization may represent common biological mechanisms linking migraine and sleep impairment. OnabotulinumtoxinA (OBT-A), an established preventive treatment for CM, inhibits the release of CGRP and other nociceptive mediators from trigeminal sensory neurons, thereby reducing peripheral and central sensitization. However, its effects on sleep quality remain incompletely characterized. The aim of this prospective real-world observational pilot study was to evaluate the impact of OBT-A treatment on sleep quality in patients with CM. Consecutive patients initiating OBT-A therapy at a tertiary headache center were enrolled and assessed at baseline (before the first OBT-A treatment cycle) and after three months, immediately before the second scheduled administration, using the Pittsburgh Sleep Quality Index (PSQI), alongside measures of migraine frequency, acute medication use, migraine-related disability, and headache impact. Fifteen patients completed follow-up evaluations. OBT-A treatment was associated with significant improvements across all clinical outcomes. Median monthly migraine days decreased from 18 to 10 (adjusted p = 0.006), while acute medication use, MIDAS scores, and HIT-6 scores were significantly reduced. Sleep quality improved markedly, with median PSQI scores decreasing from 10 to 6 (adjusted p = 0.006). Eleven of 15 patients (73.3%) achieved a \u22653-point reduction in PSQI, and the proportion of participants with pathological sleep quality (PSQI &gt; 5) decreased from 86.7% to 53.3%. Although this categorical improvement did not reach statistical significance (exact p = 0.063), likely due to the limited sample size, it may nonetheless suggest a beneficial effect on sleep quality, although the lack of statistical significance warrants cautious interpretation. These findings provide preliminary real-world evidence that OBT-A treatment is associated with improved subjective sleep quality in patients with chronic migraine. Improvements in sleep quality occurred alongside reductions in migraine frequency, acute medication use, disability, and headache impact. Given the observational and uncontrolled design of the study, it remains unclear whether sleep improvement reflects a direct effect of OBT-A or occurs secondarily to improvements in migraine-related outcomes. Larger prospective controlled studies are needed to clarify the mechanisms underlying sleep improvement and its relationship with treatment response.<\/jats:p>","DOI":"10.3390\/toxins18090379","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:10:33Z","timestamp":1788430233000},"page":"379","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["OnabotulinumtoxinA Improves Sleep Quality in Patients with Chronic Migraine: A Prospective Real-World Study"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1799-1563","authenticated-orcid":false,"given":"Giovanna","family":"Viticchi","sequence":"first","affiliation":[{"name":"Neurological Clinic, Marche Polytechnic University, Via Conca 71, 60126 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3411-2388","authenticated-orcid":false,"given":"Lorenzo","family":"Falsetti","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Marche Polytechnic University, Via Conca 71, 60020 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Marco","family":"Bartolini","sequence":"additional","affiliation":[{"name":"Neurological Clinic, Marche Polytechnic University, Via Conca 71, 60126 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"data-curation","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4869-402X","authenticated-orcid":false,"given":"Sergio","family":"Salvemini","sequence":"additional","affiliation":[{"name":"Neurological Clinic, Marche Polytechnic University, Via Conca 71, 60126 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"}]},{"given":"Gioacchino","family":"De Vanna","sequence":"additional","affiliation":[{"name":"Neurological Clinic, Marche Polytechnic University, Via Conca 71, 60126 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"}]},{"given":"Eleonora","family":"Beccacece","sequence":"additional","affiliation":[{"name":"Neurological Clinic, Marche Polytechnic University, Via Conca 71, 60126 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"resources","vocabulary":"credit"}]},{"given":"Najdi","family":"Tanuzi","sequence":"additional","affiliation":[{"name":"Neurological Clinic, Marche Polytechnic University, Via Conca 71, 60126 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"resources","vocabulary":"credit"}]},{"given":"Mauro","family":"Silvestrini","sequence":"additional","affiliation":[{"name":"Neurological Clinic, Marche Polytechnic University, Via Conca 71, 60126 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/head.13357","article-title":"Sleep and migraine: Assessment and treatment of comorbid sleep disorders","volume":"58","author":"Rains","year":"2018","journal-title":"Headache"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s10072-019-03886-4","article-title":"Influence of chronotype on migraine characteristics","volume":"40","author":"Viticchi","year":"2019","journal-title":"Neurol. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"102267","DOI":"10.1016\/j.smrv.2026.102267","article-title":"Sleep and Anti-Calcitonin Gene-Related Peptide (CGRP) Drugs: Current Evidence and Perspectives","volume":"87","author":"Boccalini","year":"2026","journal-title":"Sleep Med. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1373574","DOI":"10.3389\/fneur.2024.1373574","article-title":"Associations between the burdens of comorbid sleep problems, central sensitization, and headache-related disability in patients with migraine","volume":"15","author":"Suzuki","year":"2024","journal-title":"Front Neurol."},{"key":"ref_5","first-page":"99","article-title":"European Headache Federation Guideline on the Use of OnabotulinumtoxinA in Chronic Migraine: A Consensus Statement","volume":"21","author":"Sacco","year":"2020","journal-title":"J. Headache Pain"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1526-4610.2004.04007.x","article-title":"Regulation of Calcitonin Gene-Related Peptide Secretion from Trigeminal Nerve Cells by Botulinum Toxin Type A: Implications for Migraine Therapy","volume":"44","author":"Durham","year":"2004","journal-title":"Headache"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/j.1526-4610.2011.02022.x","article-title":"Insights into the Mechanism of OnabotulinumtoxinA in Chronic Migraine","volume":"51","author":"Durham","year":"2011","journal-title":"Headache"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/head.13849","article-title":"Mechanism of Action of OnabotulinumtoxinA in Chronic Migraine: A Narrative Review","volume":"60","author":"Burstein","year":"2020","journal-title":"Headache"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1523\/JNEUROSCI.0373-15.2015","article-title":"Migraine: Multiple Processes, Complex Pathophysiology","volume":"35","author":"Burstein","year":"2015","journal-title":"J. Neurosci."},{"key":"ref_10","first-page":"667","article-title":"Migraine and the Pathophysiology of Chronic Pain","volume":"15","author":"Ashina","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"ref_11","first-page":"673","article-title":"Insights from 25 Years of OnabotulinumtoxinA in Migraine: Mechanisms and Management","volume":"20","author":"Alpuente","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh Sleep Quality Index: A New Instrument for Psychiatric Practice and Research","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatry Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s10194-017-0723-4","article-title":"OnabotulinumtoxinA Effectiveness on Chronic Migraine, Negative Emotional States and Sleep Quality: A Single-Center Prospective Cohort Study","volume":"18","author":"Aydinlar","year":"2017","journal-title":"J. Headache Pain"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e1620","DOI":"10.1212\/WNL.0000000000012701","article-title":"Subjective Sleep Quality and Sleep Architecture in Patients with Migraine: A Meta-Analysis","volume":"97","author":"Stanyer","year":"2021","journal-title":"Neurology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e70420","DOI":"10.1111\/ene.70420","article-title":"Interventions for Migraine and Sleep: A Systematic Review Exploring Their Bidirectional Association","volume":"33","author":"Sforza","year":"2026","journal-title":"Eur. J. Neurol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s10194-023-01638-6","article-title":"Investigating the Relationship Between Sleep and Migraine in a Global Sample: A Bayesian Cross-Sectional Approach","volume":"24","author":"Stanyer","year":"2023","journal-title":"J. Headache Pain"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.sleep.2024.03.026","article-title":"Effects of prophylactic drug therapies and anti-calcitonin peptide-related monoclonal antibodies on subjective sleep quality: An Italian multicenter study","volume":"117","author":"Viticchi","year":"2024","journal-title":"Sleep Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s40263-025-01235-y","article-title":"Effect of Atogepant on Sleep Quality and Sleep-Related Adverse Events in Adult Patients with Migraine: A Prospective Observational 12-Week Study","volume":"39","author":"Iannone","year":"2025","journal-title":"CNS Drugs"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/jnnp-2018-319290","article-title":"Effects of onabotulinumtoxinA treatment for chronic migraine on common comorbidities including depression and anxiety","volume":"90","author":"Blumenfeld","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11916-017-0641-9","article-title":"Sleep in Patients with Chronic Migraine","volume":"21","author":"Yang","year":"2017","journal-title":"Curr. Pain Headache Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1468-2982.2001.00141.x","article-title":"Polysomnographic findings in nights preceding a migraine attack","volume":"21","author":"Fritzer","year":"2001","journal-title":"Cephalalgia"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s10194-019-0977-0","article-title":"The influence of rapid eye movement sleep deprivation on nociceptive transmission and the duration of facial allodynia in rats: A behavioral and Fos immunohistochemical study","volume":"20","author":"Kim","year":"2019","journal-title":"J. Headache Pain"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/head.13358","article-title":"Sleep Disorders and Migraine: Review of the Literature and Potential Pathophysiological Mechanisms","volume":"58","author":"Vgontzas","year":"2018","journal-title":"Headache"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/j.pain.0000000000001053","article-title":"Chronic Exposure to Insufficient Sleep Alters Processes of Pain Habituation and Sensitization","volume":"159","author":"Simpson","year":"2018","journal-title":"Pain"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"fcae051","DOI":"10.1093\/braincomms\/fcae051","article-title":"Unraveling the directional relationship of sleep and migraine-like pain","volume":"6","author":"Kopruszinski","year":"2024","journal-title":"Brain Commun."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1177\/0333102414541687","article-title":"Headache and Sleep: Shared Pathophysiological Mechanisms","volume":"34","author":"Holland","year":"2014","journal-title":"Cephalalgia"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/j.pain.0000000000000119","article-title":"OnabotulinumtoxinA Decreases Interictal CGRP Plasma Levels in Patients with Chronic Migraine","volume":"156","author":"Larrosa","year":"2015","journal-title":"Pain"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1177\/03331024221123058","article-title":"Effectiveness of OnabotulinumtoxinA (BOTOX\u00ae) for the Preventive Treatment of Chronic Migraine: A Meta-Analysis on 10 Years of Real-World Data","volume":"42","author":"Ducros","year":"2022","journal-title":"Cephalalgia"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jns.2014.11.004","article-title":"Chronic Migraine with Medication Overuse: Association Between Disability and Quality of Life Measures, and Impact of Disease on Patients\u2019 Lives","volume":"348","author":"Raggi","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"ref_30","first-page":"1","article-title":"Headache classification committee of the international headache society (IHS) the international classification of headache disorders, 3rd Edition","volume":"38","author":"Arnold","year":"2018","journal-title":"Cephalalgia"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1177\/0333102410364676","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial","volume":"30","author":"Aurora","year":"2010","journal-title":"Cephalalgia"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1177\/0333102410364677","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial","volume":"30","author":"Diener","year":"2010","journal-title":"Cephalalgia"}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/18\/9\/379\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:21:49Z","timestamp":1788430909000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/18\/9\/379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":32,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["toxins18090379"],"URL":"https:\/\/doi.org\/10.3390\/toxins18090379","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]}}}